(Q33653192)

28 July 2017

1 reference

title

The folate receptor as a potential therapeutic anticancer target (English)

1 reference

28 July 2017

1 reference

Gruner BA

1

1 reference

28 July 2017

Weitman SD

series ordinal

2

1 reference

28 July 2017

publication date

1 January 1998

1 reference

Investigational New Drugs

28 July 2017

published in

1 reference

28 July 2017

volume

16

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

205-219

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006147932159

28 July 2017

exact match

0 references

cites work

Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta

1 reference

12 December 2020

Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain

1 reference

12 December 2020

Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein

1 reference

12 December 2020

Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA

1 reference

12 December 2020

SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.

1 reference

12 December 2020

Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing

1 reference

12 December 2020

Genomic organization of the human folate receptor genes on chromosome 11q13

1 reference

12 December 2020

The conversion of the human membrane-associated folate binding protein (folate receptor) to the soluble folate binding protein by a membrane-associated metalloprotease

1 reference

12 December 2020

The folate receptor in central nervous system malignancies of childhood

1 reference

12 December 2020

Folate-maytansinoids: target-selective drugs of low molecular weight

1 reference

12 December 2020

Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis

1 reference

12 December 2020

Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells

1 reference

12 December 2020

Folate binding protein and the estrogen receptor in breast cancer

1 reference

12 December 2020

Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells

1 reference

12 December 2020

Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody

1 reference

12 December 2020

Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients.

1 reference

12 December 2020

Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol

1 reference

12 December 2020

UMSCC38 cells amplified at 11q13 for the folate receptor synthesize a mutant nonfunctional folate receptor

1 reference

12 December 2020

Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates

1 reference

12 December 2020

Further observations on the folate-binding factor in some leukemic cells

1 reference

12 December 2020

Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer

1 reference

12 December 2020

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

1 reference

12 December 2020

Folate-based thymidylate synthase inhibitors in cancer chemotherapy.

1 reference

12 December 2020

Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol

1 reference

12 December 2020

Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity

1 reference

12 December 2020

Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging

1 reference

12 December 2020

DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood

1 reference

12 December 2020

Cytotoxicity of momordin-folate conjugates in cultured human cells

1 reference

12 December 2020

Potocytosis: Sequestration and Transport of Small Molecules by Caveolae

1 reference

12 December 2020

Localization of the HST/FGFK gene with regard to 11q13 chromosomal breakpoint and fragile site

1 reference

12 December 2020

Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas?

1 reference

12 December 2020

Thymidylate synthase inhibitors

1 reference

12 December 2020

Three-Dimensional Molecular Modeling and Drug Design

1 reference

12 December 2020

Mapping genes according to their amplification status in tumor cells: contribution to the map of 11q13

1 reference

12 December 2020

CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma

1 reference

12 December 2020

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies

1 reference

12 December 2020

Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae

1 reference

12 December 2020

Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies.

1 reference

12 December 2020

A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

1 reference

12 December 2020

Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.

1 reference

12 December 2020

Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical

1 reference

12 December 2020

Identification of a point mutation in the folate receptor gene that confers a dominant negative phenotype

1 reference

12 December 2020

Tomudex (ZD1694): from concept to care, a programme in rational drug discovery

1 reference

12 December 2020

Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells

1 reference

12 December 2020

Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice.

1 reference

12 December 2020

Human ovarian carcinoma lysis by cytotoxic t cells targeted by bispecific monoclonal antibodies: Analysis of the antibody components

1 reference

12 December 2020

Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells.

1 reference

12 December 2020

Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol

1 reference

12 December 2020

A phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid.

1 reference

12 December 2020

Folate activity in serum and red cells of patients with cancer

1 reference

12 December 2020

Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes

1 reference

12 December 2020

Intraperitoneal radiolabeled OC 125 in patients with advanced ovarian cancer

1 reference

12 December 2020

Multiple endocrine neoplasia type 1 associated with spinal ependymoma

1 reference

12 December 2020

Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer

1 reference

12 December 2020

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer

1 reference

12 December 2020

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody

1 reference

12 December 2020

Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study

1 reference

12 December 2020

Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis

1 reference

12 December 2020

Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors

1 reference

12 December 2020

Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directions

1 reference

12 December 2020

Phase II study of ZD1694 in patients with advanced gastric cancer

1 reference

12 December 2020

Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid

1 reference

12 December 2020

In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes

1 reference

12 December 2020

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis

1 reference

12 December 2020

Targeting T cells against brain tumors with a bispecific ligand-antibody conjugate.

1 reference

12 December 2020

A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor

1 reference

12 December 2020

Role of membrane folate-binding protein in the cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cell lines in vitro

1 reference

12 December 2020

Serum folate binding capacity in patients with solid tumors

1 reference

12 December 2020

Folate and antifolate pharmacology.

1 reference

12 December 2020

Low serum-folic-acid in malignancy

1 reference

12 December 2020

Folate-binding protein is a marker for ovarian cancer

1 reference

12 December 2020

A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors

1 reference

12 December 2020

Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues

1 reference

12 December 2020

Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate

1 reference

12 December 2020

Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors.

1 reference

12 December 2020

A novel cyclin encoded by a bcl1-linked candidate oncogene

1 reference

12 December 2020

New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma

1 reference

12 December 2020

A macromolecular factor in some leukemic cells which binds folic acid

1 reference

12 December 2020

Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression

1 reference

12 December 2020

Serum folate and serum vitamin B12 in patients with malignant hematologie diseases

1 reference

12 December 2020

1 reference

12 December 2020

Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro

1 reference

12 December 2020

Serum Folate Binding Capacity in Leukemias, Liver Diseases and Pregnancy

1 reference

12 December 2020

Computer-assisted molecular modeling: indispensable tools for molecular pharmacology

1 reference

12 December 2020

A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006147932159

1 reference

Dimensions Publication ID

28 July 2017

1052493241

0 references

1 reference